Fresh off its $1.6 billion acquisition of Hitachi’s diagnostic imaging business—one of the biggest business deals in radiology history—Fujifilm is excited to provide attendees at RSNA 2021 with a sneak peek of its vision of the future. MRI, CT and ultrasound are now part of the portfolio that spans medical informatics, PACS, invitro diagnostics, CT, DR, C-arms, fluoroscopy and endoscopy.
“We now have a very unique opportunity to address the whole segmentation of the market,” says Henry Izawa, president and CEO of Fujifilm Healthcare Americas. “It’s very important for us here in the United States, as we have very high, ambitious goals for growth.”
At RSNA, Fujifilm will be previewing new lines of MRI scanners and C-arms and breakthroughs in AI and informatics, and much more.